tiprankstipranks
Advertisement
Advertisement

OCUL Stock Latest News

Ocular Therapeutix Maintained at Buy as Axpaxli’s Superior Durability Supports Unchanged $18 Price Target
RatingsOcular Therapeutix Maintained at Buy as Axpaxli’s Superior Durability Supports Unchanged $18 Price Target
3d ago
OCUL
Clear Street sees less competition for Ocular after EyePoint miss
PremiumThe Fly
Clear Street sees less competition for Ocular after EyePoint miss
3d ago
EYPT
OCUL
Ocular Therapeutix Earns Buy Rating as Axpaxli Differentiation and LUGANO TKI Data Bolster Confidence in Lead Asset
PremiumRatings
Ocular Therapeutix Earns Buy Rating as Axpaxli Differentiation and LUGANO TKI Data Bolster Confidence in Lead Asset
3d ago
OCUL
Ocular Therapeutix rises 10.4%
PremiumThe Fly
Ocular Therapeutix rises 10.4%
3d ago
OCUL
Ocular Therapeutix Faces Governance and Perception Risks from Insider Equity Compensation and Trading Practices
PremiumCompany Announcements
Ocular Therapeutix Faces Governance and Perception Risks from Insider Equity Compensation and Trading Practices
17d ago
OCUL
Ocular Therapeutix Earns Buy Rating on Reduced Regulatory Risk and Strong Axpaxli NDA Visibility
PremiumRatingsOcular Therapeutix Earns Buy Rating on Reduced Regulatory Risk and Strong Axpaxli NDA Visibility
17d ago
OCUL
Ocular Therapeutix reports Q2 EPS (35c), consensus (39c)
Premium
The Fly
Ocular Therapeutix reports Q2 EPS (35c), consensus (39c)
17d ago
OCUL
OCUL’s OTX-TKI Extension Study: Long-Term Safety Data Could Shape Wet AMD Market
Premium
Company Announcements
OCUL’s OTX-TKI Extension Study: Long-Term Safety Data Could Shape Wet AMD Market
2M ago
OCUL
Blair adds American Express, Oracle to Conviction List in monthly update
PremiumThe Fly
Blair adds American Express, Oracle to Conviction List in monthly update
2M ago
P
CW
Ocular Therapeutix price target raised to $25 from $21 at H.C. Wainwright
PremiumThe Fly
Ocular Therapeutix price target raised to $25 from $21 at H.C. Wainwright
2M ago
OCUL
Ocular Therapeutix price target raised to $30 from $24 at Baird
PremiumThe Fly
Ocular Therapeutix price target raised to $30 from $24 at Baird
2M ago
OCUL
Ocular Therapeutix trading resumes
PremiumThe Fly
Ocular Therapeutix trading resumes
2M ago
OCUL
Ocular Therapeutix Investor Day to highlight FDA alignment on Axpaxli NDA
PremiumThe FlyOcular Therapeutix Investor Day to highlight FDA alignment on Axpaxli NDA
2M ago
OCUL
Ocular Therapeutix to resume trading at 9:15 am ET
Premium
The Fly
Ocular Therapeutix to resume trading at 9:15 am ET
2M ago
OCUL
Ocular Therapeutix trading halted, news pending
Premium
The Fly
Ocular Therapeutix trading halted, news pending
2M ago
OCUL
Ocular Therapeutix Expands Equity Plan and Confirms Leadership
PremiumCompany Announcements
Ocular Therapeutix Expands Equity Plan and Confirms Leadership
2M ago
8K
OCUL
Equity-Based Pay at Ocular Therapeutix Raises Insider Trading Perception and Governance Risks
PremiumCompany Announcements
Equity-Based Pay at Ocular Therapeutix Raises Insider Trading Perception and Governance Risks
4M ago
OCUL
Analyst Reiterates Buy Rating on OCUL, Keeps Axpaxli-Driven Price Target Unchanged at $18
PremiumRatings
Analyst Reiterates Buy Rating on OCUL, Keeps Axpaxli-Driven Price Target Unchanged at $18
4M ago
OCUL
Axpaxli’s Strong Phase III Data and Favorable FDA Path Support Buy Rating and Unchanged $20 Price Target
PremiumRatings
Axpaxli’s Strong Phase III Data and Favorable FDA Path Support Buy Rating and Unchanged $20 Price Target
4M ago
OCUL
Analyst Reiterates Buy on Axpaxli Ahead of NDA Filing and Key SOL-R/SOL-X Data Catalysts
PremiumRatingsAnalyst Reiterates Buy on Axpaxli Ahead of NDA Filing and Key SOL-R/SOL-X Data Catalysts
4M ago
OCUL
Ocular Therapeutix reports Q1 EPS (40c), consensus (31c)
Premium
The Fly
Ocular Therapeutix reports Q1 EPS (40c), consensus (31c)
4M ago
OCUL
Ocular Therapeutix Inc (OCUL) Q1 Earnings Cheat Sheet
Premium
Pre-Earnings
Ocular Therapeutix Inc (OCUL) Q1 Earnings Cheat Sheet
4M ago
OCUL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >